EP2066353
COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.9.2007EP published:
2.1.2013EP application number:
07804404.7
EPO information:
European Patent Register
Max expiry date:
26.9.2027
Title:
COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY
Timeline
Today
27.9.2007EP application
2.1.2013EP Publication
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
RYAN, Anderson, JosephAddress:
Macclesfield, Cheshire SK10 4TG, GB
Priority
Number:
827483 PDate:
29.9.2006Country:
US
Classification
Categories:
C07K 16/22, A61K 31/517, A61K 39/395, A61K 31/505